This article is a methodological review to help the intensivist gain insights into the classic and sometimes arcane maze of national databases and methodologies used to determine and analyze the ICU bed supply, use, occupancy, and costs in the United States. Data for total ICU beds, use, and occupancy can be derived from two large national healthcare databases: the Healthcare Cost Report Information System maintained by the federal Centers for Medicare and Medicaid Services and the proprietary Hospital Statistics of the American Hospital Association. Two costing methodologies can be used to calculate U.S. ICU costs: the Russell equation and national projections. Both methods are based on cost and use data from the national hospital datasets or from defined groups of hospitals or patients. At the national level, an understanding of U.S. ICU bed supply, use, occupancy, and costs helps provide clarity to the width and scope of the critical care medicine enterprise within the U.S. healthcare system. This review will also help the intensivist better understand published studies on administrative topics related to critical care medicine and be better prepared to participate in their own local hospital organizations or regional critical care medicine programs. (Crit Care Med 2015; 43:2452-2459 2453 d AHA ICU bed totals do not include other special care beds.
I n 2005, ICU beds in the United States accounted for 15% of hospital beds; occupancy rates were estimated at 68% and costs were roughly $82 billion, or 0.66% of the gross domestic product (1) . These data points are highly referenced as starting parameters for the critical care medicine (CCM) landscape in the United States and are the basis for the Society of Critical Care Medicine's critical care statistics sheet (2) . However, there are many opinions about the use and costs of ICU beds and CCM resources. Thought leaders have begun to address the ramifications of increasing or decreasing the national ICU bed supply (3) (4) (5) . Along the way, two schools have emerged. The first suggests that CCM uses too many hospital beds, and ineffectively at that, and a disproportionate quantity of healthcare resources (6) . The second not only contends that additional ICU resources are needed but similarly believes that ICU beds can be used more efficiently (7) .
Whatever one's opinion on these matters, intensivists today are increasingly being asked to get more involved in hospital and healthcare network oversight of their critical care operations and to address a host of "hot-button" issues. These include complying with highly publicized patient safety and quality mandates involving CCM, participating in hospital performance metrics, optimizing ICU design, staffing and coverage, maximizing ICU throughput and patient flow, dealing with capacity strain, rationing ICU beds, containing ICU costs, standardizing ICU technologies and alarms, developing and managing rapid response and sepsis teams, fostering interdisciplinary collaboration, and interacting with hospital networks (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) .
The purpose of this methodological review is to help the intensivist gain insight into the classic and sometimes arcane national databases and methodologies used over the past few decades to analyze and determine ICU bed supply, use, occupancy, and costs in the United States. Our goal is to examine these topics from the "40,000 foot vantage point" and cultivate greater awareness of the width and scope of the national CCM enterprise. Armed with a broader perspective of administrative data, the intensivist may also attain an enhanced understanding of published studies on administrative topics related to CCM and be better equipped to participate in their own hospital's organization or regional CCM programs.
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U.S. HOSPITAL DATABASES AND CCM DATA SOURCES
Inpatient healthcare delivery in U.S. hospitals is extensively tracked and trended by two national databases: the Healthcare Cost Report Information System (HCRIS) as maintained by the federal Centers for Medicare and Medicaid Services (CMS) (19) and the proprietary Hospital Statistics of the American Hospital Association (AHA) (20) . Importantly, "current" data disseminated from these two databases are actually "old," because these large datasets do not become stable for several years following initial data acquisition.
HCRIS is built upon hospital cost reports completed annually on a mandatory basis by all non-federal hospitals that obtain Medicare funds. The HCRIS reports are audited by federally assigned Medicare Administrative Contractors. CMS does not publish detailed information from HCRIS, but selected data are available online for study (19) directly by investigators. Alternatively, the HCRIS master files may be analyzed by third-party vendors (1, 21) .
The AHA dataset contains information obtained from the yearly AHA surveys that are voluntarily completed by 83-85% of U.S. hospitals (20) . The AHA maintains a quality assurance system to test for data reliability and validity and to account for data estimates for missing hospitals. A select set of the AHA hospital data is available in the annual AHA Hospital Statistics monographs for purchase (20) . Customized analysis of the entire data set is obtained either through the AHA (AHA Health Forum LLC, Chicago, IL) or through acquisition of the dataset.
As relates to CCM, the HCRIS and AHA datasets supply several high-level data elements on ICU beds and days. Unfortunately, national data of potentially great interest to CCM researchers related to patient outcomes, ICU bed staffing, appropriateness and flexibility of ICU bed use, discharges, throughput, length of stay, occupancy, severity of illness scoring, and focused costs are not available in these datasets. To date, this type of targeted information has been extracted primarily from Project IMPACT, an ICU-centric dataset of approximately 100 ICUs in 100 hospitals (Cerner, Kansas City, MO). Project Impact, however, stopped accruing data in the first quarter of 2009 and was transitioned to APACHE Outcomes with approximately 135 ICUs in 55 hospitals (Cerner).
ICU BEDS, USE (DAYS), AND OCCUPANCY

ICU Beds
The HCRIS and AHA datasets both track ICU bed totals within predesignated ICU types that we classify into three categories: adult, child, and special ( Table 1 ). The AHA also collects data on the number of ICUs (20) , whereas HCRIS does not. The ICU bed types differ across the two datasets (22) . Hospitals, however, are left on their own to classify their ICU beds within the bed types because ICU bed allocation instructions are minimal in both datasets. In addition, the ICU bed-type classifications in both datasets have not been updated in several years; thus, hospitals may be challenged as to the exact assignment of their specialized ICU beds.
For example, HCRIS maintains separate ICU, surgical ICU, and trauma ICU categories, whereas the AHA maintains a combined medical-surgical ICU and a non-specific "other" intensive care category (Table 1) . HCRIS includes detoxification and psychiatric ICUs that are long obsolete. Neither dataset includes a separate category for neuroscience ICUs that are so prevalent today in academic medical centers. Neurosciencetype ICU beds would probably be included in the "intensive care" category in HCRIS and in the "other" intensive care in AHA. Thus, without an overhaul of the ICU types in these datasets, it would not be possible, for example, to currently determine the number of neuroscience-type (i.e., neurological, neurosurgical, or stroke) ICUs or their bed count in the United States without a hospital survey specifically targeting this question.
Both HCRIS and the AHA also include a confusing category ( Table 1) known as "other special care." This term was popular in the 1960s when ICUs were first being developed; presently, this nomenclature is rarely used. "Other special care" refers to (23), can potentially be tracked by the AHA, but not at all in HCRIS. Table 2 shows the comparison of ICU bed totals by ICU type between the HCRIS and the AHA datasets in 2010 (N. Halpern and S. Pastores, unpublished data, 2015) . The HCRIS data reflect acute care and children's hospitals nationwide. The AHA data are from their community hospital category, which we feel is comparable with HCRIS acute care. The number of reporting hospitals and total hospital beds are similar between the two datasets. However, there was a 12% CCM bed difference (12, 231 beds) between the two datasets with HCRIS posting 103,900 ICU beds and the AHA reporting 91,669 beds. This difference results in a higher percentage of hospital beds dedicated to CCM within HCRIS than in the AHA (16.2% vs 13.6%). It is possible that the step-down/intermediate/progressive beds reported by the AHA as "other special care" are actually classified as ICU beds within HCRIS, but this is merely speculative.
ICU Use (Days) and Occupancy Rates
HCRIS tracks ICU days and days available (the number of days potentially available for every operational ICU bed) for each ICU bed category. The AHA does not track ICU days or any other parameter of ICU bed use (i.e., daily census or admissions). Days can be used as a loose proxy for bed use (24) , and therefore, an average of all midnight ICU occupancy rates for the studied hospitals can be calculated (days/days available) from HCRIS (1). For example, using HCRIS data, we reported that ICUs in larger hospitals (> 500 beds) have higher occupancy rates than in smaller (< 300 beds) hospitals (25) . HCRIS data has also shown that between 2000 and 2005, national ICU occupancy rates ranged from 65% and 68% (1). In 2010, the average national ICU occupancy rate was 66% (unpublished data).
Ideally, we want to know much more than basic midnight ICU bed occupancy rates (26) . For example, the 2003 Society of Critical Care Medicine survey determined an "effective occupancy rate," based upon six throughput parameters (patients in ICU, patients waiting to get into ICU, patients awaiting transfer from ICU, total beds in ICU, closed ICU beds, and expansion ICU beds) by ICU type, hospital type, and by hospital size (27) . Occupancy was highest in surgical ICUs (79%), ICUs in federal hospitals (80%), and ICUs of hospitals with 301-750 beds (77%). An analysis of ICUs participating in Project Impact (2005-2007) studied occupancy as a continuous time variable (mean hourly occupancy 68.2%), and by ICU size (higher in ICUs with fewer beds), and hospital type (higher in academic hospitals) (24) . A second study also using Project Impact data found that mortality remained stable despite high and low occupancy (census) days (28) .
Unfortunately, occupancy data with such fine distinctions are not available from the HCRIS dataset. Nevertheless, from the perspectives of hospital and CCM administrators, average occupancy rates across all inpatient areas play a major role in hospital management due to their easy calculation, hospitalwide distribution, and simple message. Therefore, the CCM community should be aware of national occupancy-type calculations (mean midnight occupancy rate) and their associated administrative and clinical imperfections in order to deal with this type of data even at the local level. In terms of ICU use, HCRIS also tracks Medicare and Medicaid ICU days but only for traditional fee-for-service beneficiaries; Medicare and Medicaid managed care ICU days are not included (1) . Medicare ICU days, both for fee-for-service discharges and managed care, are also tracked within the Medicare Provider Analysis and Review (MEDPAR) File (29), another national CMS dataset. The MEDPAR data originate from hospital bills. Therein, ICU days are assigned using Uniform Billing 04 revenue (billing) codes for intensive care and coronary care as developed by the National Uniform Billing Committee ( Table 3 ) (30) . Of note, the Uniform Billing 04 CCM codes, like the AHA and HCRIS ICU bed types (Table 1) , have not been updated in several years.
Previous MEDPAR studies aggregated CCM data within the "intensive care" and "coronary care" categories ( (33) . Of note, there is no comparable dataset like MEDPAR for Medicaid discharges that tracks hospital and ICU stay data at the national level.
CCM COST CALCULATIONS
The national cost of CCM cannot be determined from either the AHA or the HCRIS datasets alone due to inherent fiscal data limitations within these administrative databases. Investigators instead have estimated the very "big picture" of CCM costs using one of two approaches: the Russell equation or national projections ( Fig. 1) (34) . The Russell equation, a topdown (attributable costing) approach, looks at broad patient populations without any patient-level cost detail (35, 36) . In contrast, the national projection method relies upon a bottom-up (microcosting) technique that commonly begins with all direct and indirect costs of ICU patients in selected hospitals. A more detailed discussion of the costing components (i.e., direct and indirect, fixed and variable, and marginal and opportunity) that underscore CCM healthcare economics and policy is beyond the scope of this methodological review and the reader is referred to prior articles (35, 37, 38) .
Russell Equation as a National Solution for CCM Costs
In 1984, Congress published the Health Technology Case Study on ICU outcomes, costs, and decision making that popularized the "Russell Equation" for determining CCM costs (39) . The Russell equation has since undergone several iterations, and today appears to be the most commonly used national CCM costing methodology, arguably the gold standard (34) .
The first step in solving the Russell equation (Fig. 1 , left) starts with selecting hospitals for national study using a national hospital database. Within these hospitals, the ICU and non-ICU inpatient days are determined ( Fig. 1, left, step 2) . The average cost per inpatient day, the core fiscal parameter of the equation, is also obtained from a national dataset, and a factor that relates the difference in costs of care between ICU and non-ICU (ward) beds, the ICU-to-non-ICU bed cost ratio, is selected. These parameters are then inserted into the Russell equation (Fig. 1, left, step 3) , which solves for non-ICU and ICU costs per inpatient day by estimating the proportion of daily inpatient costs likely to be incurred by patients in the ICU. The average ICU cost per inpatient day is then multiplied by the number of national ICU inpatient days to determine the ICU costs per year ( Fig. 1, left, step 4) .
The authors have used HCRIS to identify U.S. acute care hospitals with ICU beds and to determine the ICU and non-ICU days (1, 21) . We have used the comparable AHA dataset's "total nonfederal short-term general" hospital category to obtain the "adjusted expenses per inpatient day" (20) to represent the average cost per inpatient day. Finally, since the 1980s, (Fig. 1, left, step  4) , the use of ICU cost per inpatient day as a general "benchmark" for ICU daily costs has two inherent limitations. First, the costs of an ICU day are not the same for either the various categories of hospitals or regions or for the disparate ICU types and ICU patients (40) . Second, there are dynamic cost changes that occur during an ICU stay with the first days costing more than the later days (40, 41) .
Russell Equation as a Cost Adjunct for Determining CCM Costs for Medicare and the Department of Veterans Affairs
MEDPAR, similar to the HCRIS and AHA datasets, is limited in determining the ICU cost per day. MEDPAR tracks two types of Medicare hospital charges: 1) room and board charges associated with the number of days in the ICU, CCU, or ward and 2) total charges (i.e., medications, laboratory, and imaging studies) related to the inpatient stay. However, MED-PAR does not associate the individualized charges to each ICU day; therefore, the aggregate ICU charge per day cannot be determined.
Cooper and Linde-Zwirble (31) used the MEDPAR file to examine the use and costs of CCM among Medicare inpatients for fiscal year 2000. These investigators used multiple datasets including the CMS Impact File Hospital Inpatient Prospective Payment System, cost-to-charge ratios, the Federal Register, and the Russell equation as a sensitivity tool. Their goal was to analyze the distribution of cost and payments overall, by , involve four steps. The first step identifies the hospitals to be studied. The second step obtains the data to solve the Russell equation by identifying the ICU and non-ICU days and obtaining the average cost per inpatient day (left, step 2) or identifying ICU days and the associated ICU costs (right, step 2). The third step either solves for the ICU cost per inpatient day (ICU cost per inpatient day = ICU-to-non-ICU bed cost ratio × non-ICU cost per inpatient day) in the Russell equation (left, step 3) or the total costs of ICU care in the selected hospitals (right, step 3). The fourth step translates the ICU cost per inpatient day to national costs (left, step 4) or "projects or estimates" the ICU days and costs from the selected hospitals to the national level using the hospitals' projection "weights" as well as formulas for projection or estimation (right, step 4). Reproduced with permission from Intensive Care Med 2015 (34) .
hospital type and Diagnosis Related Groups (DRG) for a host of diagnoses among ICU, CCU, and ward patients. The study found that few DRGs had enough ICU exposure to ensure adequate payment and that additional DRGs for common ICU conditions were needed.
A second study, by Milbrandt et al (32) , using similar datasets, analyzed Medicare resource use between 1994 and 2004 and compared CCM and ward charges using the Russell equation to determine the annual cost differential between ICU and non-ICU areas (ICU-to-non-ICU bed cost ratio). The investigators reported that the ratio ranged from 2.55 to 1.73, and that adjusted ICU daily costs remained stable over a decade. Early iterations of the Russell equation were also studied within the Department of Veterans Affairs (DVA) in conjunction with the DVA cost distribution report between 1986 and 1992 (42) . The authors found that the Russell equation was comparable with the DVA cost dataset only when inpatient costs rather than total hospital costs were used to calculate average costs per inpatient day, and a 3:1 ICU-to-non-ICU bed cost ratio was applied.
National Projection of Hospital or State-Based Data
The first step in developing national projection estimates of CCM costs (Fig. 1, right) in the United States starts by selecting representative hospitals from either proprietary or state-based datasets. Using the ICU billing codes (Table 3 ) taken from the detailed charge databases of each hospital, the ICU days are then identified (Fig. 1, right, step 2) . The room and board costs and the costs of all billed items including medications, diagnostic, and therapeutic services, for each patient per ICU day, are totaled (Fig. 1, bottom-up, right, step 3) . Finally, the "weighted ICU and hospital data are placed into projection or estimation formulas to arrive at U.S. national estimates ( Fig. 1, right, step 4 ).
Coopersmith et al (43) used cost data from the Premier Hospital Database (Premier Healthcare Solutions, Charlotte, NC) to determine national CCM costs for 2008. This dataset, derived from the ledgers and discharge records of all participating hospitals, contains most medical and administrative costs associated with each inpatient stay including medications, laboratory, diagnostic, and therapeutic services. The study developed three ICU categories for cost analysis. They then added two additional costs: a 17% modifier to account for the CCM physician costs that were not included in the hospital charge records, and an estimate of costs for 1 year of post-ICU care recognizing the significance of post-ICU syndromes (44) . Finally, the authors used Premier's weighted projection algorithm to nationally amplify CCM costs for the entire U.S. healthcare system. The resultant data offered nine variations of CCM costs for 2008 ranging from $121B to $263B. This data ultimately were very complicated and did not offer a clear and consistent message of CCM costs although some novel costing ideas were introduced.
A second projection study by Wunsch et al (45) examined the 2005 hospital discharge data of over six million patients in six U.S. states using the Healthcare Costs and Utilization Project (HCUP) database (Agency for Healthcare Research and Quality, Rockville, MD) (46) . The researchers focused on the use and cost of mechanical ventilation in the ICU. They combined the HCUP data with hospital and patient data and cost-to-charge ratios from HCRIS and the CMS Impact File Hospital Inpatient Prospective Payment System. The authors then projected their results (180,326 hospitalizations involving mechanical ventilation) to the entire U.S. population using data from the U.S. census for 2005 and estimated that there were almost 800,000 hospitalizations nationally involving mechanical ventilation at a cost of $27B.
Comparison of the Russell Equation and the National Projection Methods
The Russell equation and the national projection methods share certain commonalities ( Table 4 ). Both methods are data input agnostic and can, therefore, be used to estimate CCM costs among well-defined or national groups of hospitals. In addition, both methods rely upon core assumptions. Within the Russell equation, we assume that the main cost variable, the average cost per inpatient day, is a valid and full representation of US inpatient costs in short-term hospitals, and that the value used for the ICU-to-non-ICU bed cost ratio is reasonable. Similarly, the projection methodology assumes that the selected hospitals are nationally representative of the entire U.S. hospital universe and the projection or estimation methods are accurate.
Even supposing that the data, the assumptions, and the projections/estimations methodologies (Table 4 ) are all technically 
FUTURE DIRECTIONS
Both the HCRIS and the AHA national datasets should be improved and data made more accessible. In our opinion, the most practical approach is to upgrade the ICU section of the proprietary AHA survey rather than HCRIS because it is unlikely that the CMS (federal government) will amend HCRIS, whereas the AHA may be more receptive to suggestions. Within the AHA survey, we recommend the following five enhancements. First, the ICU categories should be updated to match current ICU types. Second, clear instructions regarding data input by ICU type should be included with the survey. Third, the AHA should request parameters of use (days and/or daily census) by ICU type. Fourth, the AHA-adjusted inpatient cost per day calculations should be validated. Fifth, the hospital categories of the AHA should be broadened to include an "academic hospital" category. We believe that the Russell equation for estimating national CCM costs offers the cleanest, most transparent approach to estimating CCM costs. With the upgrades in the AHA dataset that we advocate, the Russell Equation could be solved quite readily with AHA data alone. Nevertheless, we understand that the projection methodology is also a recognized approach to gaining large-scale information starting with select groups of hospitals. Therefore, we suggest that the investigators be cognizant of the new approach to national estimations recently introduced by the Healthcare Cost and Utilization Project (47) .
The next generation of CCM bed and cost studies, regardless of their methodologies, should try to account for the absent CCM physician costs. In addition, large studies should analyze the United States by hospital types and regions to adjust for hospital and regional differences (48) . Adult and pediatric CCM beds and costs should also be evaluated separately. Finally, future studies of CCM Medicare and Medicaid use should address the shifting of enrollees from traditional fee-for-service to managed care. This issue is increasingly important because Medicare and Medicaid managed care now have approximately 30% and 75% penetration nationally, respectively (49, 50) .
CONCLUSIONS
This review walks the reader although the maze of arcane datasets and costing calculations for CCM in the United States. An understanding of the valuable data on ICU beds and use in the HCRIS and AHA national hospital databases and the broad outlines of the CCM costing methodologies is necessary for the intensivist to fully appreciate the subtleties of studies that address national ICU bed supply, use, occupancy rates, and costs. With this background of national level information and concepts, and in concert with the increasing focus on CCM administrative issues, we believe that the intensivist, and even the hospital administrator, will be better suited to interact with each other and have a common starting point for CCM resource discussions. We are optimistic that this review will aid intensivists and encourage young investigators as they continue to grapple with the perennial questions asked nationally and locally about whether the number and use of ICU beds is appropriate, or if CCM is properly resourced.
